METHODS	A total of 410 analyzable patients who had high-risk resected head-and-neck cancers were prospectively randomized to receive either radiation therapy ( RT : 60 Gy in 6 weeks ) or identical RT plus cisplatin , 100 mg/m ( 2 ) i.v. on days 1 , 22 , and 43 ( RT + CT ) .\